Professor Simon Broadley explains the Stage 1 results and what happens next, while Janine Watson shares why the PLATYPUS trial brings hope for people living with progressive MS.
Media Release
Early results show world-first adaptive trial in action for progressive MS
17 September 2026
A potential treatment for progressive multiple sclerosis (MS) will continue in a world-first multi-arm, multi-stage adaptive trial after showing encouraging early signs, with recruitment set to expand across Australia.
Alpha lipoic acid shows promise in Stage 1 of Octopus trial in progressive MS
17 September 2026
Results from Stage 1 of the Octopus trial find one of the trial treatments, alpha lipoic acid, shows promise in progressive MS and will continue into trial Stage 2.
What the first Octopus results mean for progressive MS
17 September 2026
Professor Simon Broadley explains the Stage 1 results and what happens next, while Janine Watson shares why the PLATYPUS trial brings hope for people living with progressive MS.
